Relationship between obesity and serum lipoproteins in children with different apolipoprotein E phenotypes: the Bogalusa Heart Study
- PMID: 8159106
- DOI: 10.1016/0026-0495(94)90079-5
Relationship between obesity and serum lipoproteins in children with different apolipoprotein E phenotypes: the Bogalusa Heart Study
Abstract
The influence of apolipoprotein (apo) E polymorphism on the association between body fatness and concentrations of serum lipoprotein variables was studied in a random subsample (n = 892) of 8- to 17-year-old children from a total community. Covariates (age, race, and sex)-adjusted mean values of percent body fat, ponderal index (wt/ht3), and subscapular skinfold thickness differed significantly among apo E phenotype groups, with the apo E2 group (n = 61) carrying E2/2 and E3/2 phenotypes having significantly (P < .01) lower values than the apo E3 group (n = 480) carrying the E3/3 phenotype. In the apo E3 group, covariates-adjusted partial correlation coefficients showed significant (P < .05 to P < .001) associations between obesity measures and lipoprotein variables studied that are generally seen in populations. However, these associations, with the exception of low-density lipoprotein (LDL) cholesterol and apo B, were altered in the other apo E phenotype groups. In the apo E2 group, obesity measures correlated significantly with triglycerides (P < .05 to P < .001), but not with very-low-density lipoprotein (VLDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and apo A-I. In contrast, in the apo E4 group (n = 212) carrying E4/3 and E4/4 phenotypes, obesity measures correlated significantly with HDL cholesterol (P < .05 to P < .001) and apo A-I (P < .01), but not with triglycerides and VLDL cholesterol. Therefore, the apo E phenotype should be taken into account in the association between body fatness and serum lipoproteins.
Similar articles
-
Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.Metabolism. 2001 Jun;50(6):696-702. doi: 10.1053/meta.2001.23299. Metabolism. 2001. PMID: 11398147
-
The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa Heart Study.Atherosclerosis. 1996 Jun;123(1-2):33-42. doi: 10.1016/0021-9150(95)05762-5. Atherosclerosis. 1996. PMID: 8782835
-
Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study.Prev Med. 1992 Mar;21(2):177-90. doi: 10.1016/0091-7435(92)90017-c. Prev Med. 1992. PMID: 1579553
-
[Apolipoprotein E and its alleles in healthy subjects and in atherosclerosis].Ann Biol Clin (Paris). 1998 Nov-Dec;56(6):651-9. Ann Biol Clin (Paris). 1998. PMID: 9853024 Review. French.
-
APO E gene and gene-environment effects on plasma lipoprotein-lipid levels.Physiol Genomics. 2000 Dec 18;4(2):101-108. doi: 10.1152/physiolgenomics.2000.4.2.101. Physiol Genomics. 2000. PMID: 11120871 Review.
Cited by
-
Effects of polymorphisms in APOB, APOE, HSD11β1, PLIN4, and ADIPOQ genes on lipid profile and anthropometric variables related to obesity in children and adolescents.Genet Mol Biol. 2018 Oct-Dec;41(4):735-741. doi: 10.1590/1678-4685-GMB-2017-0195. Epub 2018 Nov 23. Genet Mol Biol. 2018. PMID: 30507998 Free PMC article.
-
Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.Lipids Health Dis. 2016 Oct 10;15(1):176. doi: 10.1186/s12944-016-0349-6. Lipids Health Dis. 2016. PMID: 27724906 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical